Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In a recent study published in Nature Machine Intelligence, a team of researchers used a deep antibody-antigen interaction (DeepAAI) algorithm to understand the antibody representations of unseen antibodies to accelerate the discovery of novel antibodies with potential therapeutic applications. Study:…
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis (Abstract #L16). Anti-neutrophil…
In a recent study published in Eurosurveillance, researchers from Israel measured the neutralizing antibody titers against the wild-type strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the SARS-CoV-2 Omicron subvariants BA.1, BA.2, BA.2.75 and BA.5 in healthcare workers…
In a recent study posted to the Research Square* preprint server, researchers assessed the efficiency of dual direct-acting antivirals in treating persistent coronavirus disease 2019 (COVID-19). Study: Severe COVID-19 caused by persistent SARS-CoV-2 infection successfully treated with dual direct acting…
Previous research has indicated the reverse transmission of various zoonotic pathogens from humans to animals as a global concern. Furthermore, the World Organisation for Animal Health (OIE) on 6th July 2022 stated that while occasional occurrences of COVID-19 in domestic…
Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers have identified therapies that can help patients with the blood cancer multiple myeloma who try an immunotherapy known as CAR-T only to find their cancer coming back afterwards. CAR-T, short…
Monkeypox has infected more than 77,000 people in more than 100 countries worldwide, and -; similar to COVID-19 -; mutations have enabled the virus to grow stronger and smarter, evading antiviral drugs and vaccines in its mission to infect more…
In a recent study published in Cell Reports, researchers generated and characterized two monoclonal antibodies (NA8 and NE12) that target the receptor binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and exhibit neutralizing activity against…
The world has recently seen immense activity in the field of vaccine development due to the coronavirus disease 2019 (COVID-19) pandemic, as the causative virus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to emerge in new variants with…
In a recent study posted to the bioRxiv* server, researchers examined how imprinted severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) humoral immunity drives convergent evolution in continuously emerging Omicron subvariants. Notably, they investigated the humoral immune imprinting response only in recipients…